ResMed Sleep and Breathing Health — Net revenue increased by 0.4% to $1.26B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 11.5%, from $1.13B to $1.26B. Over 2 years (FY 2023 to FY 2025), Sleep and Breathing Health — Net revenue shows an upward trend with a 10.0% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
An increase indicates growing market demand, successful product adoption, or effective expansion of the patient base for sleep apnea treatments. A decrease may signal increased competition, supply chain constraints, or a slowdown in new patient diagnoses.
This metric represents the total gross sales generated from the company's primary business segment focused on respirator...
Comparable to revenue reported by other medical device manufacturers specializing in chronic respiratory conditions or home-based patient monitoring equipment.
rmd_segment_sleep_and_breathing_health_net_revenue| Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $931.25M | $931.25M | $931.25M | $931.25M | $963.04M | $1.02B | $1.05B | $1.07B | $1.07B | $1.13B | $1.13B | $1.18B | $1.17B | $1.26B | $1.26B |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | +3.4% | +5.7% | +3.1% | +2.1% | -0.3% | +5.4% | +0.4% | +4.5% | -1.0% | +7.4% | +0.4% |
| YoY Change | — | — | — | — | +3.4% | +9.3% | +12.6% | +15.0% | +10.9% | +10.6% | +7.8% | +10.2% | +9.5% | +11.6% | +11.5% |